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Background: Predictors of compliance with aspirin in children following cardiac 
catheterization have not been identified. The aim of this study is to identify the 
caregivers’ knowledge, compliance with aspirin medication, and predictors of 
compliance with aspirin in children with congenital heart disease (CHD) post 
percutaneous transcatheter occlusion. 
Methods: A cross-sectional explorative design was adopted using a self-administered 
questionnaire and conducted between May 2017 and May 2018. Recruited were 220 
caregivers of children with CHD post percutaneous transcatheter occlusion. 
Questionnaires included child and caregivers’ characteristics, a self-designed and tested 
knowledge about aspirin scale (scoring scale 0-2), and the 8-item Morisky Medication 
Adherence Scale (scoring scale 0-8). Data were analyzed using multivariate binary 
logistic regression analysis to identify predictors of compliance with aspirin. 
Results: Of the 220 eligible children and caregivers, 210 (95.5%) responded and 209 
surveys were included in the analysis. The mean score of knowledge was 7.25 (SD 
2.27). The mean score of compliance was 5.65 (SD 1.36). Child’s age, length of aspirin 
use, health insurance policies, relationship to child, monthly income, and knowledge 
about aspirin of caregivers were independent predictors of compliance with aspirin 
(p<0.05). 
Conclusion: Caregivers of children with CHD had an adequate level of knowledge 
about aspirin. Compliance to aspirin medication reported by caregivers, was low. 
Predictors of medium to high compliance with aspirin were related to the child’s age 
and socio-economic reasons. Further studies are needed to identify effective strategies 
to improve knowledge, compliance with medication and long-term outcomes of 
children with congenital heart disease. 
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Congenital heart disease (CHD) is a general term of cardiovascular malformation 
caused by incomplete development of cardiac structure during embryonic period.1 It is 
one of the most common congenital diseases in newborns. Hoffman and others have 
found that the incidence of congenital heart disease in newborns is about 1‰, and this 
ratio is even higher in death fetal or abortion.2,3 Children with congenital heart disease 
often have a series of physiological, psychological and social problems due to repeated 
infections and long treatment.4-7 The two most common types of CHD are ventricular 
septal defect (VSD) and atrial septal defect (ASD), which accounts for 31.49% and 
20.20% of CHD respectively.8,9 
With the develpment of medical technology, medical devices and surgical treatment of 
CHD, minimally invasive procedures are becoming more common in pediatric 
cardiology. Since the introduction of the Amplatzer occlusion device at the end of the 
last century, which had a positive effect on the treatment of left-to-right shunt congenital 
heart disease, interventional therapy has gradually developed into the first choice of 
treatment for some forms of CHD.10-12 Although guidelines and quality control 
standards exist for interventional catherization therapy, the prognosis and complications 
vary among children with CHD. Studies have shown that patients post percutanous 
closure continue to have changes in the aggregation and activation of platelets.13,14 A 
statement from the American Heart Association addresses that cardiac catherization 
remain associated with complications such as device embolism, marker band embolism 
(located at the tip of the sheath), and cerebral embolism.15 Krumsdorf and colleagues 
documented that thrombus formation was found in the left atrium, right atrium, or both 
in five of the 407 (1.2%) children with ASD and 15 of the 593 (2.5%) children with 
VSD.16 Therefore, in these groups of children, long-term oral anti-platelet aggregation 
medication are recommended. 
Aspirin is usually been prescribed for 6 months after ASD or VSD closure via cardiac 
catherization.17,18 The recommended aspirin dose is 3-5mg/day to avoid cardiac 
thrombosis and prevent post-interventional systemic embolism.13,19 Therefore, 
maintaining good compliance to aspirin medication is imperative to successful 
treatment and reducing complication rates in children with congenital heart disease after 
percutaneous closure. To our knowledge, there is currently no evidence describing 
predictors of compliance with aspirin in children following cardiac catheterization. 
Therefore, the aim of our study is to explore the compliance with aspirin of children 
with CHD post percutaneous transcatheter occlusion as reported by the child’ 
caregivers. Specifically, the objectives of our study are: 1) To identify the caregivers’ 
knowledge about aspirin in children with CHD; 2) to describe the compliance with 
aspirin intake in children after percutaneous transcatheter occlusion; 3) to identify 







The study adopted a cross-sectional explorative survey design. The study was 
conducted over a 12-month period; May 2017 to May 2018. Ethical approval of the 
study was obtained from the Ethical Review Board of Hunan Children’s Hospital 
(approval number: HCHLL-2017-43). The Strengthening the Reporting of 
Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting 
observational studies has been used for reporting the study.20 Specifically, the STROBE 
checklist for cross-sectional studies was used. 
Setting 
The study was performed at Hunan Children’s Hospital in Changsha, Hunan Province, 
China. The cardiology department is a tertiary center serving children with cardiac 
diseases within Hunan Province with a population of 67 million. The department 
includes the interventional pediatric cardiology unit with a catheterization laboratory 
performing over 1500 interventional therapies or cardiac catheterization. Of these, 
around 900 percutaneous transcatheter occlusion interventions are carried out in 
children with ASD or VSD. 
Participants 
Children who underwent successful atrial septal defect or ventricular septal defect 
percutaneous transcatheter occlusion and their parents. 
Sample size 
A cluster sampling method was adopted for the study. According to the single 
population proportion formula n=Z21-α/2 p(1-p)/d
2 where n is a desired sample size for 
population over than 10,000; Z1-α/2 is standard normal distribution usually set as 1.96 
(which corresponds to 95% confidence level); p means that we use estimated Omega-3 
Polyunsaturated Fatty Acid Supplementation average adherence rate at 0.8521, to 
maximize sample size; negative prevalence =1− 0.85=0.15; d is the degree of accuracy 
desired (marginal error is 0.05); then the sample size is n=1.962*0.85 (1-
0.85)/0.052=196. Adding a 10% contingency, the final sample size is 216. 
Inclusion and exclusion criteria 
Included were: Children with ventricular septal defect or atrial septal defect post 
successful percutaneous transcatheter occlusion treatment and have been prescribed 
oral aspirin for six month for anticoagulant therapy; Children with oral aspirin for more 
than one month; Children aged below nine years of age; Caregivers responsible for 
providing aspirin to the child; Caregivers able to read Chinese and complete the 
questionnaire; Caregivers able to sign the written consent form. 
Excluded were: Children with other complicated congenital malformations, such as 
complex congenital heart disease requiring surgery, congenital esophageal fistula and 
other surgical treatments; Children with other serious chronic diseases requiring long-
term oral medication, such as epilepsy or asthma. 
Instruments 
A 3-part survey was employed to measure (1) basic characteristics of children and 
caregivers, (2) aspirin-related-knowledge, and (3) compliance with medication. The 
first part included characteristics of children and caretakers: gender; age; disease type; 
length of aspirin use; relationship to child; childcare experience; marital status; 
education level; occupation; monthly income; health insurance policies. 
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The second part of the survey was aspirin-related knowledge post percutaneous 
transcatheter occlusion and was developed by the pediatric cardiovascular 
interventional therapy specialist group with six doctors and 10 nurses after a three-
round Delphi method. A pretest of this survey was performed among 10 caregivers of 
children in March 2017. The feedback of the caregivers was reviewed, and the survey 
was modified. The final version of the aspirin-related knowledge survey included six 
questions related to: major role of low-dose aspirin; reasons for taking aspirin after 
catheter interventional closure; dosage of aspirin intake; length of aspirin intake after 
interventional closure; proceedings of how to take aspirin; common side effects of 
aspirin. The survey used a 5-point scoring scale. If the question was answered correctly, 
the item received a score of 2; when the multiple-choice answers were partly correct, 
the item received a score of 1; if the answer was incorrect or the option ‘unclear’ was 
used, a score of 0 was given. The total score of this survey was 12 points; the higher 
the score, the higher the aspirin-related-knowledge. As we did not have any reference 
of this new survey, we defined a score of ≥ 6 as having an adequate level of knowledge 
about aspirin and < 6 as insufficient knowledge. The internal consistency of the survey 
resulted in a Cronbach’s α of 0.70. The content validity ratio was 0.71. 
The third part of the survey included the 8-item Morisky Medication Adherence Scale 
(MMAS-8).22 The Chinese version of the scale was used in our study.23 The answer 
options of the first seven items were Yes and No (yes=0 and no=1). The scale of the last 
items was a 5-point Likert scale: never, occasionally, sometimes, frequently, all time, 
with the scores 1, 0.75, 0.50, 0.25, and 0 points respectively. The total score of the 
MMAS-8 is 8; a score <6 indicates low compliance with medication, 6~7 medium 
compliance with medication and 8 high compliance with medication. The scale has 
been used among children with asthma and the results indicated a Cronbach’s α 
coefficient of 0.90.24 
Recruitment and Data Collection 
Recruitment of eligible children and caregivers was performed at the follow-up clinic 
one month after hospital discharge. A specialist nurse from our department always 
contacts the caregivers for a follow-up appointment. During this phone call, the 
specialist nurse provided a brief information about the study and informed the 
caregivers that they would receive a study invitation during the follow-up clinic. Once 
the children and caregivers visited the follow-up clinic, they received an invitation letter 
including the study objectives, information about the survey, assurance of 
confidentiality, and their right to withdraw at any time. After signed consent was 
obtained, the anonymous survey was distributed to the caregivers for completion while 
they visited the follow-up clinic. The doctors at the follow-up clinic were informed 
about the study. 
Statistical Analysis 
Data were entered into IBM SPSS Statistics for Windows, Version 20.0 (Armonk, NY: 
IBM Corp.). Descriptive statistics including frequency, mean, percentage, standard 
deviation was used to summarize baseline data and evaluate distribution of responses. 
Univariate analysis was performed to analyze the association between compliance with 
medication and independent variables. All variables with p<0.05 in the univariate 
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analysis were included in the multivariate binary logistic regression analysis, which 
was performed to identify potential predictors of compliance. Confidence interval (95%) 




Of the 220 eligible children and caregivers, 210 (95.5%) responded. Of these, 209 
questionnaires were valid to be included in the analysis. 
Characteristic of children and caregivers 
The characteristics of the children and caregivers are presented in Table 1. The mean 
age of the children was 4.2 years (SD 2.70). The questionnaires were mostly completed 
by mothers or fathers (66.9%). Of the 209 respondents, 103 (49.3%) had no previous 
parenting experience. 
 
Aspirin related knowledge 
The knowledge about aspirin mean scores of the caregivers was 7.25 (SD 2.27; min 2, 
max 10). 134 respondents had an overall score of ≥6, representing 64.1% of the 
respondents having an adequate level of aspirin knowledge. Detailed scores of the six 
individual questions of the knowledge about aspirin survey are presented in Table 2. 
Compliance with aspirin 
The maximum score of the MMAS-8 reported by 209 caregivers was 8, the minimum 
score was 2.5, with an overall mean score of 5.65 (SD 1.36). Of the 209 respondents, 
101 (48.3%) had a low compliance score (<6) and 108 (51.7%) respondents had a 
medium to high compliance score (6-8). Notably, only five respondents complete the 
MMAS-8 with a maximum score of 8. 
Univariate analysis of characteristics and compliance with aspirin 
The analysis revealed several predictive factors related to compliance with aspirin. 
Significant differences were observed between compliance with aspirin medication and 
the predictive factors child’s age, length of aspirin use, health insurance policies, 
relationship to child, education of caregivers, monthly income, and knowledge about 
aspirin of caregivers (Table 3). 
Multivariate binary logistic regression analysis of compliance with aspirin 
Based on the results of univariate binary logistic regression analysis, the variables 
child’s age, length of aspirin use, health insurance policies, relationship to child, 
education of caregivers, monthly income, and aspirin knowledge of caregivers were 
included in the multivariate binary logistic regression analysis. The results showed that 
child’s age, aspirin use, and knowledge about aspirin were significantly associated with 
aspirin compliance (Table 4). The variable relationship to child showed that only the 
father and mother were significantly associated with aspirin compliance. Having health 
insurance policies and a monthly income of caregivers over 5000 CNY were also 





This study explored the knowledge about aspirin and compliance with aspirin of 
children post percutaneous transcatheter occlusion as reported by caregivers and 
predictors of compliance with aspirin were identified. In our study, 209 caregivers 
participated and the majority (64%) of the caregivers had adequate knowledge of 
aspirin. Half of the caregivers reported a medium to high compliance with aspirin scores. 
The main identified predictors affecting compliance with aspirin included child’s age, 
aspirin use, and knowledge about aspirin, and socio-economic factors. 
Knowledge about aspirin 
Aspirin-related-knowledge was defined as knowledge about complications, 
administering, duration, dosage, reason, and pharmacological action of aspirin. In our 
study, the overall parental aspirin knowledge was 7.25 (max scale score 12; participants 
scores max 10) indicating that parents had possibly an adequate level of aspirin 
knowledge. A reference or cut-off point has not been identified to determine the 
minimal level of knowledge for providing optimal medication support to children. 
Duffy et al reported in their review that knowledge about aspirin and compliance was 
not optimal ranging between 72-92%.25 Of the 12 included studies in this review, none 
of the studies were related to children. Specifically, in children, Lee and colleagues 
conducted a study among parents of 87 children waiting for organ transplantation. The 
results showed that if parent have more knowledge about medication the children have 
better compliance with medication.26 Therefore, educational interventions are 
recommended as our study also confirms that aspirin knowledge was a predictor of low 
aspirin medication intake. 
Compliance with medication 
Compliance to medication is referred to the compliance level of prescribed medication 
use. The connotation includes taking the medicine according to the dose and time. 
Studies have been using the MMAS-8 to explore compliance with medication among 
patients. Basharat and colleagues identified low compliance with medication (45%) 
among 310 children with asthma.27 Another study among 75 children with sickle cell 
anemia receiving hydroxyurea documented a high compliance with medication of 
84%.28 Both study were related to children with chronic conditions which needed 
medication to enhance treatment or relieve symptoms. In our study, the compliance with 
aspirin was low to medium, 48.3%, 49.3% respectively. In our population, the cardiac 
malformations were corrected by percutaneous transcatheter occlusion. Parents might 
have believed that aspirin was not necessary to prevent post interventional 
complications. The results suggest to improve the compliance with aspirin and 
knowledge of parents. Discharge information interventions might help parents to 
increase compliance with medication regimes.29,30 
Predictors of compliance with aspirin 
The child’s compliance with medication was related to age. The results of this study 
showed that the medium to high compliance rate of children with congenital heart 
disease between 1 to 6 years old accounted for 72.4%(n=145) and the medium to high 
compliance rate of children aged 6~9 years were just 6.2%(n=64).A study among 
children (n=2860) and adolescents (n=17,179) with acne vulgaris documented 
differences in compliance with acne medication; adolescent were less likely to adhere 
9 
 
to the medication regime than children.31 In our study, all patients were under 9 years 
of age and might have less autonomous behavior ability and rely on the caregivers’ 
responsibility to adhere to the medication regime.32 Various factors might influence the 
caregiver’s level of knowledge and compliance with aspirin such as advice given by 
medical and nursing staff or family support strategies. 
The length of aspirin use is one of the predictors that can influence negatively 
compliance with aspirin. Our study documented that aspirin use more than three months 
showed a decrease in compliance rates. So far, this result has not been confirmed in 
other studies with children in cardiology. However, a study among children with anxiety 
disorders documented that treatment adherence was associated with the length of 
medication usage.33 Possible reasons for a decline in the compliance with medication 
over a longer time period could be the lack of continuous or regular health education 
support. 
Social and economic factors have been identified as predictors of compliance with 
medication. A review of studies on compliance with medication in children with 
epilepsy identified several environment-related factors influencing compliance with 
medication.33,34 For example, three identified studies in the review documented that 
support form medical and nursing staff was related to better adherence. Three other 
studies reported that better socio-economic status of the family would predict better 
compliance with medication. These factors have been confirmed in our study where 
compliance with aspirin was better when family and caretakers had a higher monthly 
income. 
Implication for clinical practice 
The attention to predictors of compliance with aspirin in children post percutaneous 
transcatheter occlusion is warranted by clinicians. Providing targeted support to parents 
or the primary caregivers might benefit the long-term adherence and reduce 
complication rates. General strategies to improve compliance with medication can be 
related to family members but should also include healthcare professionals 30,33. For 
parents, support strategies could include education or counseling, information 
brochures, and reminders. Healthcare professionals need to consider to organize 
continuous education on compliance with medication, build a stronger child-
professional relationship, or developing a multi-disciplinary teams with specific roles 
in follow-up clinics. Further studies are needed to identify effective aspirin 
prescriptions in terms of frequency and length of use for children post percutaneous 
transcatheter occlusion. 
Limitations 
This study warrants several limitations to be addressed. First, the use of self-reported 
questionnaires has its limitation because respondents might exaggerate the responses to 
the survey questions or might be uncomfortable to disclose private details. Therefore, 
we performed a rigorous method in designing the survey related to the knowledge about 
aspirin. Second, this was a single center study which might limit the generalizability of 
the findings. Third, we only recruited children and their caregivers who visited the 
follow-up clinic. This might have been a bias in the selection procedure. It is unclear 
what the knowledge and the compliance with aspirin is of the no-show children in the 
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follow-up clinic. Further investigation is warranted to determine the overall compliance 
in children post percutaneous transcatheter occlusion. 
 
CONCLUSION  
Our study documented that caregivers of children post percutaneous transcatheter 
occlusion had an adequate level of knowledge about aspirin. However, the knowledge 
level of the caregivers was correlated with a low compliance with aspirin. Several 
predictors have been identified that might influence the compliance with medication of 
the prescribed aspirin regime of six months. The compliance with medication was better 
in children who were younger and when children had health insurances, higher monthly 
incomes, better awareness of aspirin and being the father or mother of the child. Further 
studies are needed to identify the consequences of low compliance with aspirin such a 




ASD: Atrial Septal Defect 
CHD: Congenital Heart Disease 
CNY: Chinese Yuan 
MMAS-8: 8-item Morisky Medication Adherence Scale 
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Table 1. Characteristics of children and caregivers 
Children (n=209) n % 
Gender Male 106 50.7% 
Age (years) 1-6 145 69.2% 
6-9 64 30.8% 
Aspirin use (months) 1-3 138 66.0% 
3-6 71 34.0% 
Only child in family Yes 105 50.2% 
No 104 49.8% 
Heart defect ASD 91 43.5% 
VSD 118 56.5% 
Health insurance policies ≥2 64 30.6% 
1 85 40.7% 
None 60 28.7% 
Caregivers (n=209) 
Gender (male) Male 128 61.2% 
Age (years) 20-25 14 6.7 
25-40 90 43.1 
41-55 55 26.3 
≥55 50 23.9 
Relationship to child Mother 49 23.4% 
Father 91 43.5% 
Grandparent 47 22.5% 
Others 22 10.5% 
Childcare experience No 103 49.3% 
Yes 106 50.7% 
Marital status Married 137 65.6% 
Divorced or widow 72 34.4% 
Education Junior high school 135 64.6% 
Senior high school 39 18.7% 
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Bachelor or higher 35 16.7% 
Monthly income (CNY) <2000 33 15.8% 
2000-4999 98 46.9% 
5000-9999 50 23.9% 









Table 2. Knowledge about aspirin of caregivers (n=209) 
Questions Score Knowledge level 
 Min Max Mean (SD) 




Complication of aspirin 0 1 0.47 (0.500) 99 (47) 110 (53) 
How taking aspirin 0 2 0.83 (0.378) 173 (83) 36 (17) 
Length of aspirin intake 0 2 1.72 (0.692) 180 (86) 29 (14) 
Dosage of aspirin 0 2 1.97 (0.238) 206 (99) 3 (1) 
Why to take aspirin 0 2 1.19 (0.984) 124 (60) 85 (40) 
Role of low-dose aspirin 0 2 1.06 (1.001) 110 (53) 99 (47) 





Table 3 Univariate analysis characteristic and compliance with aspirin (n=209) 
Characteristics Children (n=209) 
Compliance (n, %)   
Low Medium to High χ2 P 
Gender Male 
57 (27.3) 48 (23.0) 
3.506 0.061 
 Female 
43 (20.6) 61 (29.2) 
Age (years) 
1-6 40 (19.1) 105(50.2) 
77.895 <0.001 
6-9 60 (28.7) 4 (2.0) 
Aspirin use 
(months) 
1-3 41 (19.6) 97 (46.4) 
53.549 <0.001 
3-6 59 (28.2) 12 (5.8) 
Only child in 
family 
Yes 
53 (25.4) 52 (24.9) 
0.585 0.445 
No 
47(22.5) 57 (27.3) 
Heart defect ASD 
54 (25.8) 65 (31.1) 
0.675 0.411 
VSD 




14 (6.7) 50 (23.9) 
28.492 <0.001 
1 
56 (26.8) 29 (13.9) 
None 
30 (14.4) 30 (14.4) 
Characteristics Caregivers (n=209) 
Gender Male 
58 (27.8) 70 (33.5) 
1.201 0.273 
 Female 
43 (20.6) 38 (18.2) 
Age (years) 
20-25 6 (2.9) 8 (3.8) 
1.395 0.707 
25-40 46 (22.0) 44 (21.1) 
41-55 28 (13.4) 27 (12.9) 
≥55 21 (10.0) 29 (13.9) 
Mother 






39 (18.7) 9 (4.3) 
29.518 <0.001 
Grandparent 
17 (8.1) 31 (14.8) 
Others 




54 (25.8) 49 (23.5) 
1.368 0.242 
Yes 




31 (14.8) 41 (19.6) 
1.011 0.315 
Divorced or widow 
78 (37.3) 85 (40.7) 
Education Junior high school 
87(41.6) 47(22.5) 
49.525 <0.001 
Senior high school 
12(5.7) 27(12.9) 
Bachelor or above 





29 (13.9) 3 (1.5) 
62.818 <0.001 
2000-4999 
58 (27.8) 40 (19.1) 
5000-9999 
12 (5.7) 38 (18.2) 
≥10000 






Table 4. Multivariate binary logistic regression analysis of predictors of non-
compliance with medication (n=209) 
OR=Odds Ratio; SE=Standard Error; CI=Confidence Interval 
 































-2.541 1.360 3.489 0.062 0.079 0.005 1.134 
Senior high 
school 








0 10.505 0.015 1 
  
Mother -6.191 1.943 10.150 0.001 0.002 0.000 0.092 
Father -3.724 1.563 5.678 0.017 0.024 0.001 0.516 






0 6.647 0.036 1 
  
1 2.813 1.097 6.579 0.010 16.668 1.942 143.072 







0 10.323 0.016 1 
  
5000-9999 -4.026 1.570 6.577 0.010 0.018 0.001 0.387 
2000-4999 -2.475 1.360 3.314 0.069 0.084 0.006 1.209 
<2000 -0.597 1.447 0.170 0.680 0.550 0.032 9.390 
Aspirin-knowledge 7.25 ± 2.27 -3.459 0.859 16.204 <0.001 0.031 0.006 0.170 
Constant 2.477 1.967 1.586 0.208 11.907 
  
